What do you want to hear that I haven't already posted?
$20 for a NASD stock is nothing. You need to separate KAVL from the OTC. A $20 OTC stock is unreasonable, a $20 NASD stock is normal. The liquidity currently is terrible, hence why it was so easy for the share price to drop from over $3.00 on a few million shares.
Look at the total market valuation. Right now we're trading at sub $400M market valuation. If you think we're worth $1B, then with the current O/S we should be trading at $3.53.
If we do a reverse split, where 5 shares become 1 share, then that $1B valuation is now a $17.68 share price. So if you had 1000 shares at $1.40, after the reverse split you'll have 200 shares at $7.
So if the stock went to $17.68, it would just be like it went to $3.53 with the higher O/S.
The reverse split has NO bearing on the valuation of the company, only the financials. So if the financials only get better (which why won't they?), the R/S will not matter. It will just increase the share price, allow us to trade on the NASD, and then allow institutional investors to buy into a company generating $400M for 2021.
TLDR: The R/S may have a negative impact due to emotional traders, but buy the cheapies and thank me in a few months.
News 
Market Data 
Discover 
AI
